Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.

Escudero-Esparza A, Jiang WG, Martin TA.

J Exp Clin Cancer Res. 2012 May 4;31:43. doi: 10.1186/1756-9966-31-43.

2.

Claudin-5 participates in the regulation of endothelial cell motility.

Escudero-Esparza A, Jiang WG, Martin TA.

Mol Cell Biochem. 2012 Mar;362(1-2):71-85. doi: 10.1007/s11010-011-1129-2.

PMID:
22038628
3.
4.

The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.

Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2008 Sep;33(3):585-93.

PMID:
18695890
5.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
6.

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ.

Cancer Res. 2010 Nov 1;70(21):8347-56. doi: 10.1158/0008-5472.CAN-09-4149.

7.

Claudin-16 reduces the aggressive behavior of human breast cancer cells.

Martin TA, Harrison GM, Watkins G, Jiang WG.

J Cell Biochem. 2008 Sep 1;105(1):41-52. doi: 10.1002/jcb.21797.

PMID:
18442037
8.

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE.

Int J Mol Med. 2006 Apr;17(4):583-90.

PMID:
16525713
9.

Metastasis to Bone in Human Cancer Is Associated with Loss of Occludin Expression.

Martin TA, Jordan N, Davies EL, Jiang WG.

Anticancer Res. 2016 Mar;36(3):1287-93.

PMID:
26977027
10.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024.

PMID:
21925246
11.

Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE.

Clin Cancer Res. 2005 Aug 15;11(16):6012-9.

12.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

13.

Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.

Jami MS, Hou J, Liu M, Varney ML, Hassan H, Dong J, Geng L, Wang J, Yu F, Huang X, Peng H, Fu K, Li Y, Singh RK, Ding SJ.

BMC Cancer. 2014 Mar 15;14:194. doi: 10.1186/1471-2407-14-194.

14.

Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Breast Cancer Res. 2008;10(4):R71. doi: 10.1186/bcr2136.

15.

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.

Cancer Res. 2009 Nov 15;69(22):8742-51. doi: 10.1158/0008-5472.CAN-09-1541.

16.

Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.

Tseng RC, Chang JW, Mao JS, Tsai CD, Wu PC, Lin CJ, Lu YL, Liao SY, Cheng HC, Hsu HS, Wang YC.

Oncotarget. 2015 Dec 29;6(42):44207-21. doi: 10.18632/oncotarget.6229.

17.

Claudin-20 promotes an aggressive phenotype in human breast cancer cells.

Martin TA, Lane J, Ozupek H, Jiang WG.

Tissue Barriers. 2013 Jul 1;1(3):e26518. doi: 10.4161/tisb.26518.

18.

Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.

Patsialou A, Wang Y, Pignatelli J, Chen X, Entenberg D, Oktay M, Condeelis JS.

Oncogene. 2015 May 21;34(21):2721-31. doi: 10.1038/onc.2014.226.

19.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874.

20.

Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.

Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS.

Breast Cancer Res Treat. 2012 Aug;134(3):989-1004. doi: 10.1007/s10549-012-1986-8.

PMID:
22434522

Supplemental Content

Support Center